Altamira Therapeutics Ltd. SEC filings CYTOF
Altamira Therapeutics Ltd. has 518 filings in SEC EDGAR's recent list, going back to Mar 18, 2014. Its latest annual report, Form 20-F, was filed on Apr 30, 2025 for the period ended Dec 31, 2024. The most recent current report (Form 6-K) was filed on Aug 29, 2025. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 15-12G | Deregistration | Feb 27, 2026 | — |
| 25-NSE | Delisting notice | Jun 17, 2025 | — |
| EFFECT | Filing | Sep 17, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| CORRESP | Letter to the SEC | Sep 16, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 28, 2024 | — |
| EFFECT | Filing | Jul 12, 2024 | — |
| EFFECT | Filing | Apr 17, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2024 | — |
| CORRESP | Letter to the SEC | Apr 16, 2024 | — |
| EFFECT | Filing | Jan 19, 2024 | — |
| CORRESP | Letter to the SEC | Jan 17, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 16, 2024 | — |
| EFFECT | Filing | Jul 5, 2023 | — |
| CORRESP | Letter to the SEC | Jul 5, 2023 | — |
| CORRESP | Letter to the SEC | Jul 5, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 23, 2023 | — |
| EFFECT | Filing | Jun 9, 2023 | — |
| EFFECT | Filing | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 9, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2023 | — |
| NT 20-F | Notification of late filing | May 1, 2023 | Dec 31, 2022 |
| CERT | Filing | Apr 17, 2023 | — |
| RW | Withdrawal request | Apr 13, 2023 | — |
| CERT | Filing | Apr 12, 2023 | — |
| 8-A12B | For registration of certain classes | Apr 11, 2023 | — |
| EFFECT | Filing | Mar 31, 2023 | — |
| CORRESP | Letter to the SEC | Mar 31, 2023 | — |
| CORRESP | Letter to the SEC | Mar 31, 2023 | — |
| CORRESP | Letter to the SEC | Mar 31, 2023 | — |
| CORRESP | Letter to the SEC | Mar 31, 2023 | — |
| CORRESP | Letter to the SEC | Mar 23, 2023 | — |
| CORRESP | Letter to the SEC | Mar 23, 2023 | — |
| CORRESP | Letter to the SEC | Mar 23, 2023 | — |
| CORRESP | Letter to the SEC | Mar 23, 2023 | — |
| CORRESP | Letter to the SEC | Mar 17, 2023 | — |
| CORRESP | Letter to the SEC | Mar 17, 2023 | — |
| CORRESP | Letter to the SEC | Mar 17, 2023 | — |
| CORRESP | Letter to the SEC | Mar 17, 2023 | — |
| CORRESP | Letter to the SEC | Mar 13, 2023 | — |
| CORRESP | Letter to the SEC | Mar 13, 2023 | — |
| CORRESP | Letter to the SEC | Feb 28, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 24, 2023 | — |
| EFFECT | Filing | Dec 27, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2022 | — |
| CORRESP | Letter to the SEC | Dec 22, 2022 | — |
| EFFECT | Filing | Sep 30, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2022 | — |
| CORRESP | Letter to the SEC | Sep 29, 2022 | — |
| EFFECT | Filing | Apr 25, 2022 | — |
| CORRESP | Letter to the SEC | Apr 22, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2022 | — |
| EFFECT | Filing | Apr 19, 2022 | — |
| EFFECT | Filing | Feb 17, 2022 | — |
| CORRESP | Letter to the SEC | Feb 15, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2022 | — |
| EFFECT | Filing | Dec 8, 2021 | — |
| CORRESP | Letter to the SEC | Dec 7, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 24, 2021 | — |
| EFFECT | Filing | Nov 23, 2021 | — |
| EFFECT | Filing | Jun 7, 2021 | — |
| EFFECT | Filing | Oct 30, 2020 | — |
| CORRESP | Letter to the SEC | Oct 21, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2020 | — |
| EFFECT | Filing | Jun 23, 2020 | — |
| EFFECT | Filing | Jun 23, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2020 | — |
| CORRESP | Letter to the SEC | Jun 19, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2020 | — |
| EFFECT | Filing | May 11, 2020 | — |
| CORRESP | Letter to the SEC | May 8, 2020 | — |
| UPLOAD | Letter from the SEC | May 6, 2020 | — |
| RW | Withdrawal request | Jun 26, 2019 | — |
| POS EX | Post effective amendment no. 1 to form f-1 | May 13, 2019 | — |
| EFFECT | Filing | May 10, 2019 | — |
| CORRESP | Letter to the SEC | May 8, 2019 | — |
| CORRESP | Letter to the SEC | May 8, 2019 | — |
| UPLOAD | Letter from the SEC | May 7, 2019 | — |
| EFFECT | Filing | Apr 18, 2019 | — |
| EFFECT | Filing | Apr 18, 2019 | — |
| EFFECT | Filing | Mar 27, 2019 | — |
| EFFECT | Filing | Mar 27, 2019 | — |
| 8-K12G3 | Form 8-k12g3 | Mar 18, 2019 | Mar 18, 2019 |
| EFFECT | Filing | Feb 15, 2019 | — |
| EFFECT | Filing | Feb 15, 2019 | — |
| CORRESP | Letter to the SEC | Feb 13, 2019 | — |
| CORRESP | Letter to the SEC | Feb 13, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 11, 2019 | — |
| EFFECT | Filing | Nov 14, 2018 | — |
| EFFECT | Filing | Jul 12, 2018 | — |
| EFFECT | Filing | Jun 14, 2018 | — |
| CORRESP | Letter to the SEC | Jun 12, 2018 | — |
| CORRESP | Letter to the SEC | Jun 5, 2018 | — |
| UPLOAD | Letter from the SEC | May 31, 2018 | — |
| EFFECT | Filing | May 10, 2018 | — |
| CORRESP | Letter to the SEC | May 8, 2018 | — |
| CORRESP | Letter to the SEC | Apr 27, 2018 | — |
| RW | Form rw | Apr 27, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2018 | — |
| CORRESP | Letter to the SEC | Mar 28, 2018 | — |
| 8-K12G3 | Form 8-k12g3 | Mar 20, 2018 | Mar 12, 2018 |
| 25-NSE | Delisting notice | Mar 13, 2018 | — |
| 15F-12B | Form 15f-12b | Mar 13, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 16, 2018 | — |
| D | Filing | Feb 9, 2018 | — |
| EFFECT | Filing | Oct 19, 2017 | — |
| CORRESP | Letter to the SEC | Oct 18, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 17, 2017 | — |
| EFFECT | Filing | Apr 24, 2017 | — |
| CORRESP | Letter to the SEC | Apr 20, 2017 | — |
| UPLOAD | Letter from the SEC | Apr 20, 2017 | — |
| 8-A12B/A | Form 8-a12b/a | Jun 1, 2016 | — |
| EFFECT | Filing | Sep 10, 2015 | — |
| UPLOAD | Letter from the SEC | Sep 8, 2015 | — |
| CORRESP | Letter to the SEC | Sep 8, 2015 | — |
| POS EX | Form pos ex | May 19, 2015 | — |
| EFFECT | Filing | May 14, 2015 | — |
| POS EX | Post-effective amendment no. 2 to form f-1 | Aug 18, 2014 | — |
| CT ORDER | Filing | Aug 14, 2014 | — |
| EFFECT | Filing | Aug 8, 2014 | — |
| EFFECT | Filing | Aug 5, 2014 | — |
| CORRESP | Letter to the SEC | Aug 5, 2014 | — |
| CORRESP | Letter to the SEC | Aug 5, 2014 | — |
| CERTNAS | Auto-generated paper document | Jul 29, 2014 | — |
| 8-A12B | Form 8-a | Jul 29, 2014 | — |
| CORRESP | Letter to the SEC | Jul 29, 2014 | — |
| CORRESP | Letter to the SEC | Jul 29, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2014 | — |
| CORRESP | Letter to the SEC | Jul 14, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 18, 2014 | — |
| DRS/A | Filing | Jun 6, 2014 | — |
| DRSLTR | Filing | Apr 18, 2014 | — |
| DRS/A | Filing | Apr 18, 2014 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2014 | — |
| DRS | Filing | Mar 18, 2014 | — |
Showing 138 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYTOF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Bermuda
- Headquarters
- Hamilton Hm 11, Bermuda
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1601936
- Former names
- Auris Medical Holding Ltd. (until Jul 23, 2021); Auris Medical Holding AG (until Mar 14, 2019); Auris Medical AG (until Apr 18, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.